Official Course
Description: MCCCD Approval: 6-24-08 |
|||
EXS145
2009 Spring – 2009 Fall |
LEC |
3.0 Credit(s) |
3.0 Period(s) |
Guidelines
for Exercise Testing and Prescription |
|||
Follows
the current ACSM guidelines for health appraisal, risk assessment, safety of
exercise, exercise testing, and exercise prescription. Prerequisites: None. |
|||
Go to Competencies Go to Outline
MCCCD
Official Course Competencies: |
|
|
|
EXS145 2009
Spring – 2009 Fall |
Guidelines for Exercise Testing and Prescription |
1.
|
Describe benefits and risks associated with exercise. (I) |
2.
|
Describe procedures for health screening and determining
level of risk. (I) |
3.
|
Perform exercise tests, including pretest evaluation,
physical fitness testing, and clinical exercise testing. (II) |
4.
|
Describe how to interpret the results of an exercise test.
(II) |
5.
|
Describe general principles and clinical considerations
related to influencing an exercise prescription. (III) |
6.
|
Prescribe an exercise program for cardiac and/or pulmonary
patients based on exercise tests results. (III) |
7.
|
Describe clinical considerations for prescribing exercise
programs for special populations, such as children, the elderly, and pregnant
women. (III) |
8.
|
Perform metabolic calculations. (III) |
9.
|
Describe emergency management with regards to the facility
and the participants. (III) |
10.
|
Describe environmental considerations for exercise. (III) |
11.
|
Describe pharmacology fundamentals for patients with
cardiovascular and pulmonary disease. (IV) |
Go to Description Go to top of
Competencies
MCCCD
Official Course Outline: |
||
|
||
EXS145 2009
Spring – 2009 Fall |
Guidelines for Exercise Testing and Prescription |
|
|
||
I. Health appraisal, risk
assessment, and safety of exercise A. Benefits and risks
associated with exercise 1. Public health
perspective 2. Benefits of regular
physical activity 3. Risks associated with
exercise testing 4. Risks associated with
physical activity B. Health screening and
risk stratification 1. Health screening for
physical activity 2. Risk stratification II. Exercise testing A. Pre-test evaluation 1. Clinical assessment 2. Contraindications to
exercise testing 3. Informed consent 4. Patient instructions B. Physical fitness testing
1. Purposes of fitness
testing 2. Basic principles and
guidelines 3. Body composition 4. Cardiorespiratory
endurance 5. Muscular fitness C. Clinical exercise
testing 1. Indications and
applications 2. Exercise test modalities
3. Exercise protocols 4. Measurements 5. Post-exercise period 6. Indications for exercise
test termination 7. Radionuclide exercise
testing 8. Non-exercise stress
tests or pharmacological tests 9. Considerations for pulmonary
patients 10. Summary of methodology D. Interpretation of test
data 1. Interpretation of
fitness test data 2. Graded exercise testing
as a screening tool for CAD 3. Interpretation of
responses to graded exercise testing 4. Interpretation of
clinical test data 5. Predictive value of
exercise testing 6. Interpretation of
exercise tests in pulmonary patients III. Exercise prescription A. General principles of
exercise prescription 1. Introduction 2. Cardiorespiratory
endurance 3. Caloric thresholds for
adaptation 4. Rate of progression 5. Musculoskeletal
flexibility 6. Muscular fitness 7. Program supervision B. Exercise prescription
for cardiac patients 1. Inpatient programs 2. Outpatient programs 3. Resistance training 4. Other considerations C. Exercise prescription
for pulmonary patients 1. Exercise prescription 2. Special considerations 3. Alternative modes of
exercise training 4. Program design and
supervision D. Other clinical
considerations influencing exercise prescription 1. Hypertension 2. Peripheral vascular
disease 3. Diabetes mellitus 4. Obesity E. Exercise testing and
prescription 1. Children 2. Elderly 3. Pregnancy F. Emergency management G. Metabolic calculations H. Environmental
considerations IV. Pharmacology A. Cardiac medications 1. Beta blockers 2. Nitrates 3. Calcium channel blockers
4. Digitalis 5. Diuretics 6. Vasodilators 7. Ace inhibitors 8. Antiarrhythmic
agents 9. Sympathomimetic
agents 10. Antihyperlipidemic
agents B. Pulmonary medications 1. Bronchodilators 2. Oxygen 3. Steroids |
|
|